Related content

The Role of Peroxisome Proliferator-Activated Receptor-&ggr; in Breast Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 9, 2012-11 ,pp. : 1025-1044

Bentham Science Publishers

Access to resources Recommend Favorite

No association between SOD2 Val16Ala polymorphism and breast cancer susceptibility: a meta-analysis based on 9,710 cases and 11,041 controls

By Ma Xiangyu  

Breast Cancer Research and Treatment, Vol. 122, Iss. 2, 2010-07 ,pp. : 509-514

Springer Publishing Company

Access to resources Recommend Favorite

Peroxisome proliferatoractivated receptor γ agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axis

By              

Molecular Medicine Reports, Vol. 10, Iss. 2, 2014-01 ,pp. : 695-700

Spandidos Publications

Access to resources Recommend Favorite

Lack of association between HER2 codon 655 polymorphism and breast cancer susceptibility was not credible: appraisal of a recent meta-analysis

By Lu Pei-Hua  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 597-598

Springer Publishing Company

Access to resources Recommend Favorite

BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects

By Qiu Li-Xin  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 487-490

Springer Publishing Company

Access to resources Recommend Favorite